Nurix Therapeutics, Inc.

About Nurix

Clinical-stage biopharmaceutical company focused on targeted protein degradation therapies for cancer and autoimmune diseases, including bexobrutideg (NX-5948).

Official website: nurixtx.com

Get insights on Nurix
with chemXplore Alpha

About Nurix on our platform

To provide comprehensive coverage, we aggregate data and news under the name Nurix, encompassing the following company names, divisions, and related entities:

Nurix Inc. and Kura Therapeutics, Inc..

This list encompasses current and former names, alternate names, and key divisions associated with Nurix, ensuring you can easily find all relevant information under a single, unified profile.